Lymphangioma risk factors: Difference between revisions
Jump to navigation
Jump to search
Mahshid |
Badria Munir (talk | contribs) No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{HL}} | {{CMG}} {{AE}} {{HL}} | ||
==Overview== | ==Overview== | ||
The most potent risk factor in the development of lymphangioma is the presence of genetic disorders such as [[Turner syndrome]], [[Down syndrome]], and [[Noonan syndrome]]. | The most potent risk factor in the development of lymphangioma is the presence of genetic disorders such as [[Turner syndrome]], [[Down syndrome]], and [[Noonan syndrome]].<ref name="radio">Lymphangioma. Radiopeadia (2016) http://radiopaedia.org/articles/lymphangioma Accessed on March 5, 2016</ref> | ||
==Risk Factors== | ==Risk Factors== | ||
The most potent risk factor in the development of lymphangioma is the presence of genetic disorders such as [[Turner syndrome]], [[Down syndrome]], and [[Noonan syndrome]]. | The most potent risk factor in the development of lymphangioma is the presence of genetic disorders such as [[Turner syndrome]], [[Down syndrome]], and [[Noonan syndrome]].<ref name="radio" /> | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 17:32, 10 October 2018
Lymphangioma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Lymphangioma risk factors On the Web |
American Roentgen Ray Society Images of Lymphangioma risk factors |
Risk calculators and risk factors for Lymphangioma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
The most potent risk factor in the development of lymphangioma is the presence of genetic disorders such as Turner syndrome, Down syndrome, and Noonan syndrome.[1]
Risk Factors
The most potent risk factor in the development of lymphangioma is the presence of genetic disorders such as Turner syndrome, Down syndrome, and Noonan syndrome.[1]
References
- ↑ 1.0 1.1 Lymphangioma. Radiopeadia (2016) http://radiopaedia.org/articles/lymphangioma Accessed on March 5, 2016